Global Drugs For Erectile Dysfunction Market Report 2024

Drugs For Erectile Dysfunction Global Market Report 2024 – By Drugs (Sildenafil Citrate, Mirodenafil , Vardenafil), By Mode of Administration (Oral, Topical, Injections), By End users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Drugs For Erectile Dysfunction Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Drugs For Erectile Dysfunction Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Drugs For Erectile Dysfunction Market Definition

The erectile dysfunction (ED) drugs refer to the drugs that are used to improve the effects of nitric oxide, a substance your body naturally generates that relaxes penile muscles, to treat erectile dysfunction. Erectile dysfunction is the inability to achieve or keep up a penile erection in men.

The different types of drugs in erectile dysfunction (ED) drugs are sildenafil citrate, mirodenafil, and vardenafil. Sildenafil is a drug that is used to treat erectile dysfunction and pulmonary arterial hypertension. It is offered under the trade names Viagra and others. It’s unknown whether it’s effective in treating female genital dysfunction. The different routes of administration include Oral, topical, and injections and are used by hospital pharmacies, retail pharmacies, and online pharmacies.

Drugs For Erectile Dysfunction Market Segmentation

The drugs for erectile dysfunction market covered in this report is segmented –

1) By Drugs: Sildenafil Citrate, Mirodenafil, Vardenafil

2) By Mode of Administration: Oral, Topical, Injections

3) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Global Drugs For Erectile Dysfunction Market Size 2023 to 2028: Graph

Drugs For Erectile Dysfunction Market Size 2024 And Growth Rate

The drugs for erectile dysfunction market size has grown marginally in recent years. It will grow from $4.12 billion in 2023 to $4.17 billion in 2024 at a compound annual growth rate (CAGR) of 1.2%. The growth in the historic period can be attributed to introduction of pde5 inhibitors, pharmaceutical marketing and advertising, changing societal attitudes, rise in lifestyle-induced ed cases, generic medication availability.

Drugs For Erectile Dysfunction Market Growth Forecast

The drugs for erectile dysfunction market size is expected to see marginal growth in the next few years. It will grow to $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 1.7%. The growth in the forecast period can be attributed to focus on mental health integration, shift in consumer preferences, market expansion in emerging economies, regenerative medicine exploration, biopharmaceutical innovations. Major trends in the forecast period include development of novel therapies, increasing awareness and education, lifestyle changes and health awareness, telemedicine and online consultations, innovative delivery systems.

Drugs For Erectile Dysfunction Market Driver: Chronic Diseases Drive Growth Of Erectile Dysfunction Drug Market

The drastic increase in the number of chronic diseases drives the erectile dysfunction drug market. Erectile dysfunction is mainly caused by chronic diseases resulting from a sedentary lifestyle such as cardiovascular diseases, diabetes, obesity, and high blood pressure. For instance, in September 2023, the World Health Organization (WHO) reported that chronic diseases kill 41 million people each year, equivalent to 74% of all deaths globally. Prevalence of chronic diseases increases the chances of erectile dysfunction among men, thereby driving the erectile dysfunction drug market.

Drugs For Erectile Dysfunction Market Driver: Increased Prevalence Of Hypertension Fuels Growth In Erectile Dysfunction Drug Market

The increased prevalence of hypertension is expected to propel the growth of the drugs for erectile dysfunction market going forward. Hypertension is a medical condition characterized by the long-term force of blood against the walls of the arteries, which is consistently higher than the normal range. Erectile dysfunction drugs, such as sildenafil help manage hypertension by improving blood vessel function, reducing blood pressure, and enhancing overall cardiovascular health as they promote better blood flow, potentially benefiting individuals with hypertension. For instance, in March 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, an estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, with most (two-thirds) living in low- and middle-income countries. Therefore, the increased prevalence of hypertension is driving the growth of the drugs for erectile dysfunction market.

Global Drugs For Erectile Dysfunction Market Major Players

Major companies operating in the drugs for erectile dysfunction market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Limited, Coloplast A/S, Cipla Limited, Endo International plc, Lupin Limited, Glenmark Pharmaceuticals Limited, S.K. Chemicals Co. Ltd., Dong A Pharmaceutical Co. Ltd., Zephyr Surgical Implants, Seelos Therapeutics Inc., Premedon, Meda Pharmaceuticals Inc., Futura Medical plc, Augusta Medical Systems LLC, Vivus Inc., Apricus Biosciences Inc., Bonro Medical Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Post-T-Vac Medical Inc., Adamed Pharma SA, Produtos Quimicos Farmaceuticos Ltda., Metuchen Pharmaceuticals LLC, Revive Pharmaceuticals Pvt. Ltd., Viatris Specialty LLC

Global Drugs For Erectile Dysfunction Market Restraint: Side Effects Of Erectile Dysfunction Drugs Hinder Market Growth

Side effects associated with the drugs had a negative impact on the growth of the drugs for the erectile dysfunction market during the forecast period. Side effects associated with drugs could decrease patient compliance and raise concerns among healthcare professionals, leading to reduced adoption and trust in the medication, thus hindering market expansion. For instance, in July 2022, according to study conducted by RxList Inc., a US-based healthcare company, involving 511 men who found recurring side effects following Viagra consumption. The most common side effects were headaches, flushing, indigestion, and nasal congestion. After taking 50 mg of Viagra, 21% of patients experienced headaches, 19% experienced flushing, 9% experienced dyspepsia, 2% experienced abnormal vision, 3% experienced nausea, 4% experienced back pain and nasal congestion, 2% experienced rash, 2% experienced myalgia, and 4% experienced dizziness.

Global Drugs For Erectile Dysfunction Market Trend: Innovative Drug Delivery Techniques Enhance The Erectile Dysfunction Drug Market

New drug delivery techniques such as the use of pellets and creams are being implemented by many companies in the erectile dysfunction drugs market. Pellets and creams will have more efficacy and performance in erectile dysfunction and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of the erectile dysfunction drug market. For example, In September 2022, Lupin, an India-based pharmaceutical company launched Sildenafil for oral suspension, 10 mg/mL with the approval of the United States Food and Drug Administration (FDA). This drug is for erectile dysfunction with unique dosages.

Global Drugs For Erectile Dysfunction Market Trend: Combination Capsules Gain Traction In The Erectile Dysfunction Drug Market

Major companies operating in the drugs for erectile dysfunction market are increasing their focus on introducing combination capsules such as therapy capsule to maximize revenue in the market. Tamsulosin and Tadalafil is a combination of medications used to treat both benign prostatic hyperplasia (BPH) and erectile dysfunction. For instance, in September 2023, Akums Drugs & Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a therapy capsule for the treatment of erectile dysfunction and enlarged prostate in the Indian market. The capsule contains a combination of Tamsulosin and Tadalafil, which has demonstrated significant improvements in BPH (Benign Prostatic Hyperplasia) and the Erectile Dysfunction Index. The combination significantly improves total, voting, and other symptoms associated with BPH. The launch of this therapy capsule is expected to provide a new treatment option for patients suffering from both conditions.

Regional Insights For The Global Drugs For Erectile Dysfunction Market

North America was the largest region in the erectile dysfunction (ED) drugs market in 2023. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the drugs for erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs for erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The erectile dysfunction (ED) drugs market consists of sales Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The erectile dysfunction (ED) drugs market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction (ED) drugs market statistics, including erectile dysfunction (ED) drugs industry global market size, regional shares, competitors with erectile dysfunction (ED) drugs market share, detailed erectile dysfunction (ED) drugs market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction (ED) drugs industry. This erectile dysfunction (ED) drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Drugs For Erectile Dysfunction Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $4.17 billion
Revenue Forecast In 2033 $4.46 billion
Growth Rate CAGR of 1.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drugs: Sildenafil Citrate, Mirodenafil , Vardenafil
2) By Mode of Administration: Oral, Topical, Injections
3) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Sanofi S.A.; GlaxoSmithKline plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Boston Scientific Corporation; Sun Pharmaceutical Industries Limited; Coloplast A/S; Cipla Limited; Endo International plc; Lupin Limited; Glenmark Pharmaceuticals Limited; S.K. Chemicals Co. Ltd.; Dong A Pharmaceutical Co. Ltd.; Zephyr Surgical Implants; Seelos Therapeutics Inc.; Premedon; Meda Pharmaceuticals Inc.; Futura Medical plc; Augusta Medical Systems LLC; Vivus Inc.; Apricus Biosciences Inc.; Bonro Medical Inc.; Cristalia Produtos Quimicos Farmaceuticos Ltda.; Post-T-Vac Medical Inc.; Adamed Pharma SA; Produtos Quimicos Farmaceuticos Ltda.; Metuchen Pharmaceuticals LLC; Revive Pharmaceuticals Pvt. Ltd.; Viatris Specialty LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Drugs For Erectile Dysfunction Market Characteristics

    3. Drugs For Erectile Dysfunction Market Trends And Strategies

    4. Drugs For Erectile Dysfunction Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Drugs For Erectile Dysfunction Market Size and Growth

    5.1. Global Drugs For Erectile Dysfunction Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Drugs For Erectile Dysfunction Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Drugs For Erectile Dysfunction Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Drugs For Erectile Dysfunction Market Segmentation

    6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Sildenafil Citrate

    Mirodenafil

    Vardenafil

    6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Topical

    Injections

    6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Drugs For Erectile Dysfunction Market Regional And Country Analysis

    7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Drugs For Erectile Dysfunction Market

    8.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Drugs For Erectile Dysfunction Market

    9.1. China Drugs For Erectile Dysfunction Market Overview

    9.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Drugs For Erectile Dysfunction Market

    10.1. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Drugs For Erectile Dysfunction Market

    11.1. Japan Drugs For Erectile Dysfunction Market Overview

    11.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Drugs For Erectile Dysfunction Market

    12.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Drugs For Erectile Dysfunction Market

    13.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Drugs For Erectile Dysfunction Market

    14.1. South Korea Drugs For Erectile Dysfunction Market Overview

    14.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Drugs For Erectile Dysfunction Market

    15.1. Western Europe Drugs For Erectile Dysfunction Market Overview

    15.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Drugs For Erectile Dysfunction Market

    16.1. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Drugs For Erectile Dysfunction Market

    17.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Drugs For Erectile Dysfunction Market

    18.1. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Drugs For Erectile Dysfunction Market

    19.1. Italy Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Drugs For Erectile Dysfunction Market

    20.1. Spain Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Drugs For Erectile Dysfunction Market

    21.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview

    21.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Drugs For Erectile Dysfunction Market

    22.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Drugs For Erectile Dysfunction Market

    23.1. North America Drugs For Erectile Dysfunction Market Overview

    23.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Drugs For Erectile Dysfunction Market

    24.1. USA Drugs For Erectile Dysfunction Market Overview

    24.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Drugs For Erectile Dysfunction Market

    25.1. Canada Drugs For Erectile Dysfunction Market Overview

    25.2. Canada Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Drugs For Erectile Dysfunction Market

    26.1. South America Drugs For Erectile Dysfunction Market Overview

    26.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Drugs For Erectile Dysfunction Market

    27.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Drugs For Erectile Dysfunction Market

    28.1. Middle East Drugs For Erectile Dysfunction Market Overview

    28.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Drugs For Erectile Dysfunction Market

    29.1. Africa Drugs For Erectile Dysfunction Market Overview

    29.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles

    30.1. Drugs For Erectile Dysfunction Market Competitive Landscape

    30.2. Drugs For Erectile Dysfunction Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi S.A.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Drugs For Erectile Dysfunction Market Other Major And Innovative Companies

    31.1. Eli Lilly and Company

    31.2. Teva Pharmaceutical Industries Ltd.

    31.3. Boston Scientific Corporation

    31.4. Sun Pharmaceutical Industries Limited

    31.5. Coloplast A/S

    31.6. Cipla Limited

    31.7. Endo International plc

    31.8. Lupin Limited

    31.9. Glenmark Pharmaceuticals Limited

    31.10. S.K. Chemicals Co. Ltd.

    31.11. Dong A Pharmaceutical Co. Ltd.

    31.12. Zephyr Surgical Implants

    31.13. Seelos Therapeutics Inc.

    31.14. Premedon

    31.15. Meda Pharmaceuticals Inc.

    32. Global Drugs For Erectile Dysfunction Market Competitive Benchmarking

    33. Global Drugs For Erectile Dysfunction Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market

    35. Drugs For Erectile Dysfunction Market Future Outlook and Potential Analysis

    35.1 Drugs For Erectile Dysfunction Market In 2028 - Countries Offering Most New Opportunities

    35.2 Drugs For Erectile Dysfunction Market In 2028 - Segments Offering Most New Opportunities

    35.3 Drugs For Erectile Dysfunction Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson & Johnson Services Inc. Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Sanofi S.A. Financial Performance
  • Table 78: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Services Inc. Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Sanofi S.A. Financial Performance
  • Figure 78: GlaxoSmithKline plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the drugs for erectile dysfunction market?

The erectile dysfunction (ED) drugs refer to the drugs that are used to improve the effects of nitric oxide, a substance your body naturally generates that relaxes penile muscles, to treat erectile dysfunction. Erectile dysfunction is the inability to achieve or keep up a penile erection in men. For further insights on the drugs for erectile dysfunction market, request a sample here

How will the drugs for erectile dysfunction market drivers and restraints affect the drugs for erectile dysfunction market dynamics? What forces will shape the drugs for erectile dysfunction industry going forward?

The drugs for erectile dysfunction market major growth driver - chronic diseases drive growth of erectile dysfunction drug market. For further insights on the drugs for erectile dysfunction market, request a sample here

What is the forecast market size or the forecast market value of the drugs for erectile dysfunction market ?

The drugs for erectile dysfunction market size has grown marginally in recent years. It will grow from $4.12 billion in 2023 to $4.17 billion in 2024 at a compound annual growth rate (CAGR) of 1.2%. The growth in the historic period can be attributed to introduction of pde5 inhibitors, pharmaceutical marketing and advertising, changing societal attitudes, rise in lifestyle-induced ed cases, generic medication availability. The drugs for erectile dysfunction market size is expected to see marginal growth in the next few years. It will grow to $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 1.7%. The growth in the forecast period can be attributed to focus on mental health integration, shift in consumer preferences, market expansion in emerging economies, regenerative medicine exploration, biopharmaceutical innovations. Major trends in the forecast period include development of novel therapies, increasing awareness and education, lifestyle changes and health awareness, telemedicine and online consultations, innovative delivery systems. For further insights on the drugs for erectile dysfunction market, request a sample here

How is the drugs for erectile dysfunction market segmented?

The drugs for erectile dysfunction market is segmented
1) By Drugs: Sildenafil Citrate, Mirodenafil , Vardenafil
2) By Mode of Administration: Oral, Topical, Injections
3) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies For further insights on the drugs for erectile dysfunction market,
request a sample here

Which region has the largest share of the drugs for erectile dysfunction market? What are the other regions covered in the report?

North America was the largest region in the erectile dysfunction (ED) drugs market in 2023. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the drugs for erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the drugs for erectile dysfunction market, request a sample here.

Who are the major players in the drugs for erectile dysfunction market?

Major companies operating in the drugs for erectile dysfunction market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Limited, Coloplast A/S, Cipla Limited, Endo International plc, Lupin Limited, Glenmark Pharmaceuticals Limited, S.K. Chemicals Co. Ltd., Dong A Pharmaceutical Co. Ltd., Zephyr Surgical Implants, Seelos Therapeutics Inc., Premedon, Meda Pharmaceuticals Inc., Futura Medical plc, Augusta Medical Systems LLC, Vivus Inc., Apricus Biosciences Inc., Bonro Medical Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Post-T-Vac Medical Inc., Adamed Pharma SA, Produtos Quimicos Farmaceuticos Ltda., Metuchen Pharmaceuticals LLC, Revive Pharmaceuticals Pvt. Ltd., Viatris Specialty LLC For further insights on the drugs for erectile dysfunction market, request a sample here.

What are the key trends in the drugs for erectile dysfunction market?

Major trend in the drugs for erectile dysfunction market - innovative drug delivery techniques enhance the erectile dysfunction drug market. For further insights on the drugs for erectile dysfunction market, request a sample here.

What are the major opportunities in the drugs for erectile dysfunction market? What are the strategies for the drugs for erectile dysfunction market?

For detailed insights on the major opportunities and strategies in the drugs for erectile dysfunction market, request a sample here.

How does the drugs for erectile dysfunction market relate to the overall economy and other similar markets?

For detailed insights on drugs for erectile dysfunction market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the drugs for erectile dysfunction industry?

For detailed insights on the mergers and acquisitions in the drugs for erectile dysfunction industry, request a sample here.

What are the key dynamics influencing the drugs for erectile dysfunction market growth? SWOT analysis of the drugs for erectile dysfunction market.

For detailed insights on the key dynamics influencing the drugs for erectile dysfunction market growth and SWOT analysis of the drugs for erectile dysfunction industry, request a sample here.